Examkin

Soru

Zorluk: OrtaNormal Pregnancy and Prenatal Care

A 31-year-old woman, gravida 2, para 1, presents to the office for a scheduled prenatal evaluation at 32 weeks gestation. She reports feeling well, with appropriate fetal movement and no abdominal pain, itching, nausea, or vomiting. Her prior pregnancy was uncomplicated and resulted in a spontaneous vaginal delivery at term. Vital signs are within normal limits. Physical examination reveals a gravid uterus consistent with dates and normal fetal heart tones. She recently participated in an employer-sponsored health screening program and brings the laboratory report for review. The results show:

Laboratory ParameterValueReference Range (Nonpregnant)
Hemoglobin11.2 g/dL12.0–16.0 g/dL
Platelets180,000/mm³150,000–400,000/mm³
Aspartate aminotransferase (AST)18 U/L8–20 U/L
Alanine aminotransferase (ALT)22 U/L8–20 U/L
Alkaline phosphatase (ALP)310 U/L40–120 U/L
Total bilirubin0.6 mg/dL0.1–1.0 mg/dL

Which of the following is the most appropriate management regarding these laboratory findings?

  1. Continue standard prenatal monitoring without further hepatic testingCevap
  2. B
    Measure fasting serum bile acid concentrations
  3. C
    Perform an abdominal ultrasound of the biliary tree
  4. D
    Obtain a fractionated alkaline phosphatase or gamma-glutamyl transferase level
  5. E
    Initiate symptomatic treatment with ursodeoxycholic acid

Cevap

Continue standard prenatal monitoring without further hepatic testing
The correct management is to continue routine prenatal care without additional hepatic testing. During normal pregnancy, the placenta produces a heat-stable isozyme of alkaline phosphatase (ALP) that enters the maternal bloodstream. This typically results in a 2- to 4-fold increase in total serum ALP levels, peaking in the third trimester. Because this patient is entirely asymptomatic and her other hepatic markers (AST, ALT, and total bilirubin) are strictly within normal limits, this isolated elevation represents a well-recognized and benign physiologic adaptation to pregnancy. No further evaluation is indicated.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient is an asymptomatic pregnant woman at 32 weeks gestation with no complaints of right upper quadrant pain, jaundice, or pruritus.
Establishing the presence or absence of symptoms is critical for differentiating physiologic changes from pathologic conditions like cholestasis or gallstone disease.
2
Interpret the laboratory findings.
The patient has an isolated elevation of alkaline phosphatase (ALP) at nearly three times the nonpregnant upper limit of normal, with normal hemoglobin, platelets, AST, ALT, and bilirubin.
Pattern recognition of hepatic panels helps narrow the differential diagnosis. An isolated ALP elevation in late pregnancy is distinct from a transaminitis.
3
Correlate the laboratory data with normal physiologic adaptations of pregnancy.
The placenta produces a specific heat-stable isozyme of alkaline phosphatase, which enters the maternal circulation and causes total serum ALP levels to normally rise 2- to 4-fold during the late second and third trimesters.
Recognizing this physiologic process prevents the misdiagnosis of hepatobiliary disease.
4
Determine the appropriate management.
Because the clinical picture represents a normal, expected finding in pregnancy, no additional diagnostic workup or medical intervention is required.
Unnecessary testing in asymptomatic patients with expected physiologic changes increases healthcare costs and patient anxiety.

Anahtar Kavram

During the late second and third trimesters of a normal pregnancy, total serum alkaline phosphatase (ALP) levels physiologically increase 2- to 4-fold due to the production of a placental ALP isozyme.
Bu soruyu puanla

Konular

Normal Pregnancy and Prenatal Care

Bu konudan daha fazla soru